RAMACHANDRA SUMANT purchased 200K shares of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market purchase worth $115.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/25/2025ACC: 0001415889-25-008942
Director
Since Oct 2024
+200K
Net shares
Net buyer
$115.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+200K
Price / share
$0.58
Trade value
$115.22K
% of position
New position
3/21/2025
0.00→200K
Total
Net shares
+200K
Net value
$115.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/21/2025 | P · Purchase | +200K | $0.58 | $115.22K | New position | 0.00 | 200K |
| Total | +200K | $115.22K | ||||||
Derivative Transactions0
No derivative transactions reported